1-3 of 3
Anders Waage
Close
Sort by
Journal Articles

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial

Clinical Trials & Observations
Rowan Kuiper, Sonja Zweegman, Mark van Duin, Martin H. van Vliet, Erik H. van Beers, Belinda Dumee, Michael Vermeulen, Jasper Koenders, Bronno van der Holt, Heleen Visser-Wisselaar, Markus Hansson, Annette W. G. van der Velden, H. Berna Beverloo, Marian Stevens-Kroef, Mark-David Levin, Annemiek Broijl, Anders Waage, Pieter Sonneveld
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6298–6309.
https://doi.org/10.1182/bloodadvances.2020002838
Published: 2020
Includes: Supplemental data
Journal Articles

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk, Mariaserena Giliberto, Glenn Buene, Anders Sundan, Anders Waage, Anne-Marit Sponaas, Therese Standal
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2656–2666.
https://doi.org/10.1182/bloodadvances.2017010801
Published: 2017
Includes: Supplemental data
Journal Articles

Direct evidence for a polygenic etiology in familial multiple myeloma

Britt-Marie Halvarsson, Anna-Karin Wihlborg, Mina Ali, Konstantinos Lemonakis, Ellinor Johnsson, Abhishek Niroula, Carrie Cibulskis, Niels Weinhold, Asta Försti, Evren Alici, Christian Langer, Michael Pfreundschuh, Hartmut Goldschmidt, Ulf-Henrik Mellqvist, Ingemar Turesson, Anders Waage, Kari Hemminki, Todd Golub, Hareth Nahi, Urban Gullberg, Markus Hansson, Björn Nilsson
Journal: Blood Advances
Blood Adv (2017) 1 (10): 619–623.
https://doi.org/10.1182/bloodadvances.2016003111
Published: 2017
Includes: Supplemental data